Table 4.
Descriptive statistics in patients with and without Ebola virus disease associated uveitis
| Demographic, clinical feature or examination finding |
No Uveitis | EVD Associated Uveitis |
P value |
|---|---|---|---|
| Number of Patients | 75 | 21 | |
| Age (median) | 39 | 36 | 0.53 |
| Gender (% male) | 48 | 38 | 0.42 |
| Number of Days in ETU (median) | 14 | 17 | 0.27 |
| Symptoms (patients, %) | |||
| Blurry Vision | 56 (75) | 17 (81) | 0.55 |
| Photophobia | 52 (69) | 13 (62) | 0.52 |
| Pain | 43 (57) | 11 (52) | 0.69 |
| Tearing | 49 (65) | 11 (52) | 0.28 |
| Redness | 32 (43) | 11 (52) | 0.43 |
| Floaters | 37 (49) | 8 (38) | 0.32 |
| Joint Pain | 64 (85) | 16 (76) | 0.33 |
| Hair Loss | 24 (32) | 8 (38) | 0.60 |
| Fatigue | 13 (17) | 7 (33) | 0.13 |
| Hearing Loss | 8 (11) | 2 (10) | 1.00 |
|
Ocular Exam Findings (patients,%) |
|||
| Anterior Segment Cell | 0 | 3 (14) | 0.01* |
| Keratic Precipitates | 0 | 3 (14) | 0.01* |
| Corneal Edema | 0 | 1 (5) | 0.22 |
| Posterior Synechiae | 1 (1) | 8 (38) | <0.001* |
| Vitritis | 0 | 4 (19) | 0.002* |
| Chorioretinal Scars | 2 (3) | 13 (62) | <0.001* |
*
Statistically significant difference between EVD survivors with and without uveitis, P < 0.05 considered significant